Back

Left ventricular mass by three-dimensional echocardiography is associated with myocardial replacement fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: Imaging to unravel left ventricular hypertrophy 3D Echocardiography EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Valeria Rella

Italian Auxological Institute San Luca Hospital, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Echocardiographic feature analysis for differentiating myocardial hypertrophy etiologies using artificial intelligence
Doctor I. Moon (Bucheon, KR)
Abstract Slides Video
Presentation thumbnail
Unfavorable systemic and coronary hemodynamic profile of left ventricular hypercontractile phenotype in hypertrophic cardiomyopathy
Professor K. Wierzbowska-Drabik (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Sensitivity and specificity of relative apical sparing pattern of global longitudinal strain in the diagnosis of cardiac amyloidosis: a systematic review and meta-analysis
Mr O. Ahmad (SA)
Abstract Slides Video
Presentation thumbnail
Late gadolinium enhancement prognostic value in hypertrophic cardiomyopathy
Doctor J. Florence (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging to unravel left ventricular hypertrophy
Video

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.
thumbnail
Congress Presentation
Early detection of treatment response to mavacamten in hypertrophic obstructive cardiomyopathy with severe mitral regurgitation using magnetocardiography
thumbnail
Congress Presentation
Additional value of left atrial and left ventricular strain in hypertrophic cardiomyopathy patients with low to intermediate risk of sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources